PreveCeutical Medical Inc.
PRVCF
$0.02
$0.000.00%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 256.00K | 261.50K | 430.70K | 460.60K | 810.30K |
| Depreciation & Amortization | 2.90K | 3.00K | 2.60K | 2.60K | 2.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 273.50K | 279.30K | 498.70K | 512.10K | 851.20K |
| Operating Income | -273.50K | -279.30K | -498.70K | -512.10K | -851.20K |
| Income Before Tax | -381.20K | -389.30K | 850.60K | -623.00K | -907.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -381.20K | -389.30K | 850.60K | -623.00K | -907.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 76.40K | -- | 29.40K |
| Net Income | -381.20K | -389.30K | 926.90K | -623.00K | -877.50K |
| EBIT | -273.50K | -279.30K | -498.70K | -512.10K | -851.20K |
| EBITDA | -270.50K | -276.30K | -496.10K | -509.50K | -848.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 602.97M | 602.97M | 594.99M | 572.14M | 569.46M |
| Average Diluted Shares Outstanding | 602.97M | 602.97M | 594.99M | 572.14M | 569.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |